Skip to main content
. 2019 Jun;11(6):2458–2469. doi: 10.21037/jtd.2019.05.81

Figure 2.

Figure 2

The mSHOX2 levels before and two cycles after therapy for stage IV lung cancer patients. The before-after plot is shown in (A), and data from the same patient is connected by dashed line to show the mSHOX2 level change. The scatter plot is shown in (B), and bars represent mean values with 95% CI. The paired mSHOX2 levels before and two cycles after therapy were shown in (C) in descending order of the pre-therapeutic mSHOX2 level. Solid dots and blank dots represent mSHOX2 level before and two cycles after therapy, respectively.